Details for New Drug Application (NDA): 062363
✉ Email this page to a colleague
NDA 062363 describes CLEOCIN T, which is a drug marketed by Pfizer and Pharmacia And Upjohn and is included in four NDAs. It is available from two suppliers. Additional details are available on the CLEOCIN T profile page.
The generic ingredient in CLEOCIN T is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
The generic ingredient in CLEOCIN T is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
Summary for 062363
| Tradename: | CLEOCIN T |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | clindamycin phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | EQ 1% BASE | ||||
| Approval Date: | Feb 8, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
